First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.4 USD 3.85%
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

516.6m
-6%
Assets
Growth Rates:
1 Year
+14%
3 Years
+24%
5 Years
+214%
7 Years
+135%
10 Years
+716%
157.2m
-8%
Liabilities
Growth Rates:
1 Year
+156%
3 Years
+235%
5 Years
+524%
7 Years
+234%
10 Years
+1 706%
359.5m
-5%
Equity
Growth Rates:
1 Year
-8%
3 Years
-3%
5 Years
+158%
7 Years
+108%
10 Years
+558%

Balance Sheet Decomposition
Aurinia Pharmaceuticals Inc

516.6m
Assets
157.2m
Liabilities
516.6m
Assets
157.2m
Liabilities
Current Assets 398.2m
Cash & Short-Term Investments 319.4m
Receivables 28.9m
Other Current Assets 49.9m
Non-Current Assets 118.4m
Long-Term Investments 199k
PP&E 112m
Intangibles 4.8m
Other Non-Current Assets 1.5m
Current Liabilities 71.1m
Accounts Payable 5.7m
Accrued Liabilities 44.2m
Other Current Liabilities 21.2m
Non-Current Liabilities 86.1m
Long-Term Debt 67.5m
Other Non-Current Liabilities 18.6m

Balance Sheet
Aurinia Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
23
6
40
166
118
306
272
232
94
49
Cash
0
6
0
0
0
0
0
0
0
0
Cash Equivalents
23
0
40
166
118
306
272
232
94
49
Short-Term Investments
10
10
0
8
8
0
126
234
295
302
Total Receivables
0
0
0
0
0
0
1
15
14
24
Accounts Receivables
0
0
0
0
0
0
1
15
14
24
Other Receivables
0
0
0
0
0
0
1
0
0
0
Inventory
0
0
0
0
0
0
14
19
25
40
Other Current Assets
1
1
2
2
7
9
6
13
15
11
Total Current Assets
34
17
41
175
133
315
419
513
443
425
PP&E Net
0
0
0
0
0
0
10
10
9
117
PP&E Gross
0
0
0
0
0
0
10
10
9
117
Accumulated Depreciation
0
3
0
0
0
0
0
1
2
2
Intangible Assets
19
17
16
14
13
9
9
8
6
5
Long-Term Investments
0
0
0
0
0
0
24
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
12
13
2
Total Assets
52
N/A
34
-36%
57
+70%
190
+233%
146
-23%
324
+122%
464
+43%
543
+17%
471
-13%
548
+16%
Liabilities
Accounts Payable
3
2
3
4
3
4
3
4
12
4
Accrued Liabilities
0
1
3
4
4
7
23
32
29
50
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
15
Other Current Liabilities
0
0
2
0
0
0
6
5
6
8
Total Current Liabilities
3
4
8
8
7
11
32
41
46
77
Long-Term Debt
0
0
0
0
0
0
0
0
0
75
Other Liabilities
16
10
13
16
26
14
24
24
19
17
Total Liabilities
19
N/A
14
-26%
21
+54%
24
+15%
33
+38%
26
-23%
56
+118%
64
+15%
65
+2%
170
+160%
Equity
Common Stock
260
262
300
499
505
747
944
1 177
1 185
1 200
Retained Earnings
237
257
280
351
416
473
575
756
864
942
Additional Paid In Capital
12
16
17
18
25
25
39
59
86
121
Other Equity
1
1
1
1
1
1
1
1
1
1
Total Equity
34
N/A
20
-41%
36
+80%
166
+360%
113
-32%
299
+165%
408
+37%
479
+17%
405
-15%
378
-7%
Total Liabilities & Equity
52
N/A
34
-36%
57
+70%
190
+233%
146
-23%
324
+122%
464
+43%
543
+17%
471
-13%
548
+16%
Shares Outstanding
Common Shares Outstanding
31
32
53
84
86
112
127
142
142
144

See Also

Summary
AUPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
AUPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AUPH stock valuation using valuation multiples.
Wall Street Estimates
AUPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AUPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.